Guardant Health, Inc. provided earnings guidance for the year 2024. The company expects full year 2024 revenue excluding screening to be in the range of $655 million to $670 million, representing growth of 16% to 19% compared to full year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.37 USD | +15.07% | +18.49% | -17.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.30% | 2.74B | |
-27.67% | 9.87B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 772M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M | |
+12.46% | 219M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Earnings Guidance for the Year 2024